"Shardul Amarchand Mangaldas Advises on ₹3,093 Crore Share Sale in Cohance Lifesciences"

"Shardul Amarchand Mangaldas & Co acted as the legal advisor for Jusmiral Holdings Limited's sale of an 8.93% stake in Cohance Lifesciences Limited for ₹3,093 crore. The transaction team was led by partner Ambarish, with contributions from other associates and counsel on securities law. This follows SAM's previous advisory roles in the acquisition and merger of Cohance with Suven Pharmaceuticals."

Shardul Amarchand Mangaldas & Co acted as the legal advisor for Jusmiral Holdings Limited in an on-market sale of an 8.93% shareholding in Cohance Lifesciences Limited for ₹3,093 crore. The transaction involved the sale of shares in Cohance Lifesciences Limited, which is a significant move in the market, reflecting the ongoing activities and strategic decisions within the pharmaceutical sector. The transaction team from Shardul Amarchand Mangaldas was led by Ambarish (Partner), with support from Krishaal Morjaria (Principal Associate) and Varun Natarajan (Senior Associate). Additionally, Kanwardeep Singh Kapany (Counsel) provided advice on securities law aspects, while Ameya Gokhale (Partner) and Kriti Kalyani (Principal Associate) also contributed to the transaction.

"Shardul Amarchand Mangaldas Advises on ₹3,093 Crore Share Sale in Cohance Lifesciences"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads